1014613-05-8 Usage
General Description
4-Bromo-2-methyl-1-phenylsulfonyl-7-azaindole is a chemical compound with the molecular formula C16H13BrN2O2S and a molecular weight of 372.25 g/mol. It is an azaindole derivative with a bromo substituent at the 4-position and a methyl and phenylsulfonyl group at the 2-position. 4-Bromo-2-methyl-1-phenylsulfonyl-7-azaindole has potential applications in organic synthesis and medicinal chemistry due to its unique structure and functional groups. It may be used as a building block in the synthesis of pharmaceuticals and agrochemicals, and may exhibit biological activity in the treatment of various diseases or conditions. Further research and exploration of its properties and potential applications may be warranted.
Check Digit Verification of cas no
The CAS Registry Mumber 1014613-05-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,1,4,6,1 and 3 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1014613-05:
(9*1)+(8*0)+(7*1)+(6*4)+(5*6)+(4*1)+(3*3)+(2*0)+(1*5)=88
88 % 10 = 8
So 1014613-05-8 is a valid CAS Registry Number.
1014613-05-8Relevant articles and documents
Pyrrolo[2,3-b]pyridine derivatives as potent Bruton's tyrosine kinase inhibitors
Zhao, Xinge,Huang, Wei,Wang, Yazhou,Xin, Minhang,Jin, Qiu,Cai, Jianfeng,Tang, Feng,Zhao, Yong,Xiang, Hua
, p. 4344 - 4353 (2015)
A series of pyrrolo[2,3-b]pyridine-based derivatives were designed as potent Bruton's tyrosine kinase (BTK) inhibitors by using a scaffold-hopping strategy. Structure-activity relationship studies identified five compounds (3n, 3p, 3q, 3r, and 3s) with IC
Azaquinazoline Inhibitors Of Atypical Protein Kinase C
-
, (2015/12/24)
The present application provides a compound of formula (I) and/or a salt thereof, wherein R1, G, and X are as defined herein. A compound of formula (I) and/or its salts have aPKC inhibitory activity, and may be used to treat proliferative disor
NOVEL COMPOUNDS
-
, (2011/06/25)
The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of PI3-kinase activity.